nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—ESR1—atherosclerosis	0.37	1	CbGaD
Medroxyprogesterone Acetate—CYP2C8—Simvastatin—atherosclerosis	0.0415	0.128	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Lovastatin—atherosclerosis	0.0406	0.125	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Pravastatin—atherosclerosis	0.0406	0.125	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Rosuvastatin—atherosclerosis	0.0311	0.0957	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Simvastatin—atherosclerosis	0.0289	0.0889	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Lovastatin—atherosclerosis	0.0283	0.087	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Pravastatin—atherosclerosis	0.0283	0.087	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Ezetimibe—atherosclerosis	0.0181	0.0556	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Rosuvastatin—atherosclerosis	0.0181	0.0556	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Simvastatin—atherosclerosis	0.0168	0.0517	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Pravastatin—atherosclerosis	0.0165	0.0506	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Lovastatin—atherosclerosis	0.0165	0.0506	CbGbCtD
Medroxyprogesterone Acetate—SHBG—hindlimb—atherosclerosis	0.00354	0.146	CbGeAlD
Medroxyprogesterone Acetate—AR—penis—atherosclerosis	0.00336	0.138	CbGeAlD
Medroxyprogesterone Acetate—PGR—artery—atherosclerosis	0.00195	0.0804	CbGeAlD
Medroxyprogesterone Acetate—PGR—blood vessel—atherosclerosis	0.00152	0.0626	CbGeAlD
Medroxyprogesterone Acetate—ESR1—blood vessel—atherosclerosis	0.00119	0.049	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—adipose tissue—atherosclerosis	0.000884	0.0364	CbGeAlD
Medroxyprogesterone Acetate—SHBG—connective tissue—atherosclerosis	0.000866	0.0356	CbGeAlD
Medroxyprogesterone Acetate—PGR—connective tissue—atherosclerosis	0.00078	0.0321	CbGeAlD
Medroxyprogesterone Acetate—SHBG—cardiovascular system—atherosclerosis	0.000753	0.031	CbGeAlD
Medroxyprogesterone Acetate—PGR—cardiovascular system—atherosclerosis	0.000679	0.0279	CbGeAlD
Medroxyprogesterone Acetate—SHBG—adipose tissue—atherosclerosis	0.000664	0.0273	CbGeAlD
Medroxyprogesterone Acetate—AR—connective tissue—atherosclerosis	0.000621	0.0256	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—liver—atherosclerosis	0.00062	0.0255	CbGeAlD
Medroxyprogesterone Acetate—ESR1—connective tissue—atherosclerosis	0.00061	0.0251	CbGeAlD
Medroxyprogesterone Acetate—Ethynodiol—ESR1—atherosclerosis	0.000599	0.427	CrCbGaD
Medroxyprogesterone Acetate—PGR—adipose tissue—atherosclerosis	0.000598	0.0246	CbGeAlD
Medroxyprogesterone Acetate—AR—cardiovascular system—atherosclerosis	0.000541	0.0223	CbGeAlD
Medroxyprogesterone Acetate—ESR1—cardiovascular system—atherosclerosis	0.000531	0.0218	CbGeAlD
Medroxyprogesterone Acetate—AR—adipose tissue—atherosclerosis	0.000477	0.0196	CbGeAlD
Medroxyprogesterone Acetate—ESR1—adipose tissue—atherosclerosis	0.000468	0.0193	CbGeAlD
Medroxyprogesterone Acetate—SHBG—liver—atherosclerosis	0.000466	0.0192	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—connective tissue—atherosclerosis	0.00045	0.0185	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—cardiovascular system—atherosclerosis	0.000392	0.0161	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—cardiovascular system—atherosclerosis	0.000388	0.016	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—adipose tissue—atherosclerosis	0.000345	0.0142	CbGeAlD
Medroxyprogesterone Acetate—AR—liver—atherosclerosis	0.000334	0.0138	CbGeAlD
Medroxyprogesterone Acetate—ESR1—liver—atherosclerosis	0.000328	0.0135	CbGeAlD
Medroxyprogesterone Acetate—Fluoxymesterone—ESR1—atherosclerosis	0.000297	0.212	CrCbGaD
Medroxyprogesterone Acetate—CYP2C8—liver—atherosclerosis	0.00027	0.0111	CbGeAlD
Medroxyprogesterone Acetate—Back pain—Ezetimibe—atherosclerosis	0.000252	0.00144	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000251	0.00143	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Ezetimibe—atherosclerosis	0.00025	0.00143	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00025	0.00143	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Simvastatin—atherosclerosis	0.00025	0.00143	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Lovastatin—atherosclerosis	0.000249	0.00142	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Pravastatin—atherosclerosis	0.000249	0.00142	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Simvastatin—atherosclerosis	0.000248	0.00142	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Lovastatin—atherosclerosis	0.000246	0.00141	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Niacin—atherosclerosis	0.000245	0.0014	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Simvastatin—atherosclerosis	0.000245	0.0014	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Niacin—atherosclerosis	0.000244	0.0014	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Pravastatin—atherosclerosis	0.000244	0.00139	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Simvastatin—atherosclerosis	0.000243	0.00139	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Lovastatin—atherosclerosis	0.000243	0.00139	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—liver—atherosclerosis	0.000242	0.00997	CbGeAlD
Medroxyprogesterone Acetate—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000242	0.00138	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Ezetimibe—atherosclerosis	0.000241	0.00138	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Pravastatin—atherosclerosis	0.000241	0.00138	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—liver—atherosclerosis	0.00024	0.00989	CbGeAlD
Medroxyprogesterone Acetate—Malaise—Lovastatin—atherosclerosis	0.00024	0.00137	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Pravastatin—atherosclerosis	0.000239	0.00137	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Simvastatin—atherosclerosis	0.000239	0.00137	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Lovastatin—atherosclerosis	0.000239	0.00136	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Ezetimibe—atherosclerosis	0.000238	0.00136	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Niacin—atherosclerosis	0.000238	0.00136	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Niacin—atherosclerosis	0.000235	0.00134	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Ezetimibe—atherosclerosis	0.000235	0.00134	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000233	0.00133	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Simvastatin—atherosclerosis	0.000233	0.00133	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Niacin—atherosclerosis	0.000232	0.00132	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Pravastatin—atherosclerosis	0.000231	0.00132	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Rosuvastatin—atherosclerosis	0.000231	0.00132	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Simvastatin—atherosclerosis	0.00023	0.00132	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Ezetimibe—atherosclerosis	0.00023	0.00132	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Rosuvastatin—atherosclerosis	0.00023	0.00131	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Simvastatin—atherosclerosis	0.00023	0.00131	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Niacin—atherosclerosis	0.000228	0.0013	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Niacin—atherosclerosis	0.000228	0.0013	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Pravastatin—atherosclerosis	0.000228	0.0013	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Simvastatin—atherosclerosis	0.000227	0.0013	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Lovastatin—atherosclerosis	0.000226	0.00129	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Lovastatin—atherosclerosis	0.000226	0.00129	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Lovastatin—atherosclerosis	0.000226	0.00129	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Lovastatin—atherosclerosis	0.000225	0.00129	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Rosuvastatin—atherosclerosis	0.000225	0.00129	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Niacin—atherosclerosis	0.000225	0.00129	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Simvastatin—atherosclerosis	0.000224	0.00128	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Niacin—atherosclerosis	0.000224	0.00128	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Lovastatin—atherosclerosis	0.000223	0.00128	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Simvastatin—atherosclerosis	0.000223	0.00128	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Ezetimibe—atherosclerosis	0.000222	0.00127	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Ezetimibe—atherosclerosis	0.000222	0.00127	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Ezetimibe—atherosclerosis	0.000222	0.00127	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Niacin—atherosclerosis	0.000222	0.00127	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Pravastatin—atherosclerosis	0.000221	0.00127	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Lovastatin—atherosclerosis	0.000221	0.00126	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Pravastatin—atherosclerosis	0.00022	0.00126	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00022	0.00126	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Pravastatin—atherosclerosis	0.00022	0.00126	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Niacin—atherosclerosis	0.000219	0.00125	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Ezetimibe—atherosclerosis	0.000219	0.00125	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Rosuvastatin—atherosclerosis	0.000219	0.00125	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Lovastatin—atherosclerosis	0.000219	0.00125	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Pravastatin—atherosclerosis	0.000218	0.00125	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Ezetimibe—atherosclerosis	0.000217	0.00124	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Lovastatin—atherosclerosis	0.000217	0.00124	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Pravastatin—atherosclerosis	0.000216	0.00123	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Lovastatin—atherosclerosis	0.000215	0.00123	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Ezetimibe—atherosclerosis	0.000214	0.00123	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000213	0.00122	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Lovastatin—atherosclerosis	0.000212	0.00121	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Simvastatin—atherosclerosis	0.000211	0.00121	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Simvastatin—atherosclerosis	0.000211	0.00121	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Simvastatin—atherosclerosis	0.000211	0.00121	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Ezetimibe—atherosclerosis	0.000211	0.00121	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000211	0.00121	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Simvastatin—atherosclerosis	0.000211	0.00121	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Pravastatin—atherosclerosis	0.00021	0.0012	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000209	0.0012	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Simvastatin—atherosclerosis	0.000209	0.00119	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Ezetimibe—atherosclerosis	0.000208	0.00119	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Niacin—atherosclerosis	0.000208	0.00119	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Pravastatin—atherosclerosis	0.000208	0.00119	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000208	0.00119	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Pravastatin—atherosclerosis	0.000208	0.00119	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Lovastatin—atherosclerosis	0.000207	0.00118	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Ezetimibe—atherosclerosis	0.000207	0.00118	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Pravastatin—atherosclerosis	0.000205	0.00117	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Niacin—atherosclerosis	0.000205	0.00117	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Niacin—atherosclerosis	0.000205	0.00117	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Simvastatin—atherosclerosis	0.000204	0.00117	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Rosuvastatin—atherosclerosis	0.000203	0.00116	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Simvastatin—atherosclerosis	0.000203	0.00116	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Simvastatin—atherosclerosis	0.000203	0.00116	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Pravastatin—atherosclerosis	0.000203	0.00116	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Rosuvastatin—atherosclerosis	0.000202	0.00116	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Pravastatin—atherosclerosis	0.000202	0.00115	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Niacin—atherosclerosis	0.000202	0.00115	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Simvastatin—atherosclerosis	0.000201	0.00115	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Niacin—atherosclerosis	0.0002	0.00115	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Simvastatin—atherosclerosis	0.000199	0.00114	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000197	0.00113	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Lovastatin—atherosclerosis	0.000196	0.00112	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Lovastatin—atherosclerosis	0.000195	0.00111	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Niacin—atherosclerosis	0.000194	0.00111	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Niacin—atherosclerosis	0.000194	0.00111	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000194	0.00111	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Simvastatin—atherosclerosis	0.000193	0.00111	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Lovastatin—atherosclerosis	0.000193	0.00111	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000193	0.0011	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Ezetimibe—atherosclerosis	0.000192	0.0011	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Pravastatin—atherosclerosis	0.000191	0.00109	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Pravastatin—atherosclerosis	0.000191	0.00109	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Pravastatin—atherosclerosis	0.000191	0.00109	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Ezetimibe—atherosclerosis	0.000191	0.00109	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Lovastatin—atherosclerosis	0.000191	0.00109	CcSEcCtD
Medroxyprogesterone Acetate—Drospirenone—PTGS2—atherosclerosis	0.000191	0.136	CrCbGaD
Medroxyprogesterone Acetate—Anxiety—Pravastatin—atherosclerosis	0.000191	0.00109	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Niacin—atherosclerosis	0.00019	0.00109	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Ezetimibe—atherosclerosis	0.00019	0.00108	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Pravastatin—atherosclerosis	0.000189	0.00108	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000188	0.00108	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Lovastatin—atherosclerosis	0.000188	0.00108	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Ezetimibe—atherosclerosis	0.000187	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Lovastatin—atherosclerosis	0.000187	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Niacin—atherosclerosis	0.000186	0.00106	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Niacin—atherosclerosis	0.000186	0.00106	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Lovastatin—atherosclerosis	0.000185	0.00106	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Pravastatin—atherosclerosis	0.000185	0.00106	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Ezetimibe—atherosclerosis	0.000185	0.00106	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000185	0.00106	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000184	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Rosuvastatin—atherosclerosis	0.000184	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Simvastatin—atherosclerosis	0.000183	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Pravastatin—atherosclerosis	0.000183	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Pravastatin—atherosclerosis	0.000183	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Ezetimibe—atherosclerosis	0.000183	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Niacin—atherosclerosis	0.000183	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—liver—atherosclerosis	0.000183	0.00754	CbGeAlD
Medroxyprogesterone Acetate—Infection—Pravastatin—atherosclerosis	0.000182	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Simvastatin—atherosclerosis	0.000182	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Ezetimibe—atherosclerosis	0.000182	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Niacin—atherosclerosis	0.000182	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Rosuvastatin—atherosclerosis	0.000181	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Niacin—atherosclerosis	0.000181	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Simvastatin—atherosclerosis	0.000181	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Niacin—atherosclerosis	0.00018	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Pravastatin—atherosclerosis	0.000179	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Lovastatin—atherosclerosis	0.000179	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Simvastatin—atherosclerosis	0.000178	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Niacin—atherosclerosis	0.000177	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000177	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Pravastatin—atherosclerosis	0.000177	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Simvastatin—atherosclerosis	0.000176	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Ezetimibe—atherosclerosis	0.000175	0.001	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000175	0.001	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Rosuvastatin—atherosclerosis	0.000175	0.001	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Simvastatin—atherosclerosis	0.000175	0.001	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Pravastatin—atherosclerosis	0.000175	0.000999	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Niacin—atherosclerosis	0.000174	0.000995	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000174	0.000994	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Simvastatin—atherosclerosis	0.000173	0.000991	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Lovastatin—atherosclerosis	0.000172	0.000985	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Lovastatin—atherosclerosis	0.000171	0.00098	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Lovastatin—atherosclerosis	0.000171	0.00098	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00017	0.00097	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Rosuvastatin—atherosclerosis	0.000169	0.000967	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Ezetimibe—atherosclerosis	0.000169	0.000966	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Niacin—atherosclerosis	0.000168	0.000963	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Ezetimibe—atherosclerosis	0.000168	0.000961	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Ezetimibe—atherosclerosis	0.000168	0.000961	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Niacin—atherosclerosis	0.000167	0.000956	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Simvastatin—atherosclerosis	0.000167	0.000955	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000167	0.000955	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Niacin—atherosclerosis	0.000166	0.000949	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000166	0.000948	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Pravastatin—atherosclerosis	0.000166	0.000948	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Niacin—atherosclerosis	0.000166	0.000946	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Pravastatin—atherosclerosis	0.000165	0.000941	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Niacin—atherosclerosis	0.000164	0.000937	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Pravastatin—atherosclerosis	0.000163	0.000934	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Niacin—atherosclerosis	0.000162	0.000925	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Pravastatin—atherosclerosis	0.000161	0.000923	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Rosuvastatin—atherosclerosis	0.000161	0.000922	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Rosuvastatin—atherosclerosis	0.000161	0.000921	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Simvastatin—atherosclerosis	0.000161	0.000921	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Niacin—atherosclerosis	0.000161	0.000919	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Simvastatin—atherosclerosis	0.00016	0.000916	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Simvastatin—atherosclerosis	0.00016	0.000916	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Rosuvastatin—atherosclerosis	0.00016	0.000916	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Lovastatin—atherosclerosis	0.00016	0.000913	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Pravastatin—atherosclerosis	0.000159	0.000911	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Pravastatin—atherosclerosis	0.000158	0.000904	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Pravastatin—atherosclerosis	0.000157	0.000896	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Ezetimibe—atherosclerosis	0.000157	0.000896	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Lovastatin—atherosclerosis	0.000156	0.000889	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Lovastatin—atherosclerosis	0.000153	0.000877	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Ezetimibe—atherosclerosis	0.000153	0.000872	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Niacin—atherosclerosis	0.000152	0.00087	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Rosuvastatin—atherosclerosis	0.000152	0.000869	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Pravastatin—atherosclerosis	0.000151	0.000864	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Ezetimibe—atherosclerosis	0.00015	0.00086	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00015	0.000857	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Simvastatin—atherosclerosis	0.000149	0.000854	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Lovastatin—atherosclerosis	0.000148	0.000848	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Niacin—atherosclerosis	0.000148	0.000846	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Niacin—atherosclerosis	0.000147	0.000842	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Niacin—atherosclerosis	0.000147	0.000842	CcSEcCtD
Medroxyprogesterone Acetate—Progesterone—ESR1—atherosclerosis	0.000147	0.105	CrCbGaD
Medroxyprogesterone Acetate—Urticaria—Pravastatin—atherosclerosis	0.000146	0.000833	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Simvastatin—atherosclerosis	0.000145	0.000832	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Ezetimibe—atherosclerosis	0.000145	0.000832	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Pravastatin—atherosclerosis	0.000145	0.000829	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Pravastatin—atherosclerosis	0.000145	0.000829	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Simvastatin—atherosclerosis	0.000143	0.00082	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Lovastatin—atherosclerosis	0.000143	0.00082	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Ezetimibe—atherosclerosis	0.000141	0.000804	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Simvastatin—atherosclerosis	0.000139	0.000793	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Lovastatin—atherosclerosis	0.000138	0.000788	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Niacin—atherosclerosis	0.000137	0.000784	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Lovastatin—atherosclerosis	0.000137	0.000781	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Lovastatin—atherosclerosis	0.000137	0.000781	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Lovastatin—atherosclerosis	0.000136	0.000776	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Ezetimibe—atherosclerosis	0.000135	0.000773	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Pravastatin—atherosclerosis	0.000135	0.000772	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Simvastatin—atherosclerosis	0.000134	0.000767	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Ezetimibe—atherosclerosis	0.000134	0.000767	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Ezetimibe—atherosclerosis	0.000134	0.000766	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Niacin—atherosclerosis	0.000134	0.000764	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Ezetimibe—atherosclerosis	0.000133	0.000762	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Niacin—atherosclerosis	0.000132	0.000753	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Pravastatin—atherosclerosis	0.000132	0.000752	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Pravastatin—atherosclerosis	0.00013	0.000742	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Simvastatin—atherosclerosis	0.000129	0.000737	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Lovastatin—atherosclerosis	0.000129	0.000736	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Simvastatin—atherosclerosis	0.000128	0.000731	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Simvastatin—atherosclerosis	0.000128	0.00073	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Niacin—atherosclerosis	0.000127	0.000728	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Simvastatin—atherosclerosis	0.000127	0.000726	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Ezetimibe—atherosclerosis	0.000126	0.000722	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Pravastatin—atherosclerosis	0.000125	0.000717	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Niacin—atherosclerosis	0.000123	0.000704	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Pravastatin—atherosclerosis	0.000121	0.000693	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Simvastatin—atherosclerosis	0.00012	0.000689	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Niacin—atherosclerosis	0.000118	0.000677	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Niacin—atherosclerosis	0.000117	0.000671	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Niacin—atherosclerosis	0.000117	0.000671	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Niacin—atherosclerosis	0.000117	0.000667	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Pravastatin—atherosclerosis	0.000117	0.000666	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Pravastatin—atherosclerosis	0.000116	0.000661	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Pravastatin—atherosclerosis	0.000115	0.00066	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Pravastatin—atherosclerosis	0.000115	0.000657	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Niacin—atherosclerosis	0.000111	0.000632	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Pravastatin—atherosclerosis	0.000109	0.000623	CcSEcCtD
Medroxyprogesterone Acetate—Methyltestosterone—ALB—atherosclerosis	0.000107	0.0761	CrCbGaD
Medroxyprogesterone Acetate—Testosterone—ALB—atherosclerosis	6.19e-05	0.0442	CrCbGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ABCG5—atherosclerosis	1.38e-05	0.000133	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.38e-05	0.000133	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PLTP—atherosclerosis	1.38e-05	0.000133	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—INS—atherosclerosis	1.38e-05	0.000132	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCL2—atherosclerosis	1.36e-05	0.00013	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NCF1—atherosclerosis	1.35e-05	0.00013	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—FABP4—atherosclerosis	1.35e-05	0.00013	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—LCAT—atherosclerosis	1.35e-05	0.00013	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—AKT1—atherosclerosis	1.34e-05	0.000129	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—LPA—atherosclerosis	1.33e-05	0.000128	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IGF1—atherosclerosis	1.33e-05	0.000128	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PDGFB—atherosclerosis	1.33e-05	0.000128	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOA4—atherosclerosis	1.32e-05	0.000127	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTGS2—atherosclerosis	1.32e-05	0.000127	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP7A1—atherosclerosis	1.3e-05	0.000125	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—PPARG—atherosclerosis	1.3e-05	0.000125	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AGT—atherosclerosis	1.3e-05	0.000125	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—BGN—atherosclerosis	1.29e-05	0.000124	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.28e-05	0.000123	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APOA5—atherosclerosis	1.28e-05	0.000123	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCR2—atherosclerosis	1.27e-05	0.000122	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EDNRA—atherosclerosis	1.27e-05	0.000122	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—LEP—atherosclerosis	1.27e-05	0.000122	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—APOE—atherosclerosis	1.27e-05	0.000122	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CYBA—atherosclerosis	1.27e-05	0.000122	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SERPINE1—atherosclerosis	1.27e-05	0.000122	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CAV1—atherosclerosis	1.26e-05	0.000121	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—APOA1—atherosclerosis	1.26e-05	0.000121	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.24e-05	0.000119	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GHRL—atherosclerosis	1.24e-05	0.000119	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PLAT—atherosclerosis	1.24e-05	0.000119	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PARP1—atherosclerosis	1.24e-05	0.000119	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.24e-05	0.000119	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	1.23e-05	0.000118	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—STAT3—atherosclerosis	1.23e-05	0.000118	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.22e-05	0.000117	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ESR1—atherosclerosis	1.21e-05	0.000117	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—PPARA—atherosclerosis	1.21e-05	0.000116	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NOS3—atherosclerosis	1.21e-05	0.000116	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.21e-05	0.000116	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.2e-05	0.000116	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.2e-05	0.000115	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—F2—atherosclerosis	1.2e-05	0.000115	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.2e-05	0.000115	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.2e-05	0.000115	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—PPARA—atherosclerosis	1.19e-05	0.000115	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ALOX5—atherosclerosis	1.19e-05	0.000114	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.18e-05	0.000114	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MAPK3—atherosclerosis	1.18e-05	0.000113	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—SERPINE1—atherosclerosis	1.17e-05	0.000112	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.15e-05	0.000111	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PIK3CG—atherosclerosis	1.15e-05	0.00011	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TGFB1—atherosclerosis	1.14e-05	0.00011	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.14e-05	0.000109	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOA2—atherosclerosis	1.14e-05	0.000109	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.14e-05	0.000109	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.14e-05	0.000109	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.12e-05	0.000108	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.12e-05	0.000108	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.1e-05	0.000106	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KNG1—atherosclerosis	1.09e-05	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—INS—atherosclerosis	1.09e-05	0.000104	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—LPA—atherosclerosis	1.09e-05	0.000104	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AGTR1—atherosclerosis	1.08e-05	0.000104	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—ESR1—atherosclerosis	1.08e-05	0.000104	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CXCL8—atherosclerosis	1.07e-05	0.000103	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCL2—atherosclerosis	1.07e-05	0.000103	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—NAMPT—atherosclerosis	1.07e-05	0.000103	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.06e-05	0.000102	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—LIPC—atherosclerosis	1.06e-05	0.000102	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PLG—atherosclerosis	1.06e-05	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APOC3—atherosclerosis	1.05e-05	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—BGN—atherosclerosis	1.05e-05	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IGF1—atherosclerosis	1.05e-05	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—LDLR—atherosclerosis	1.05e-05	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.04e-05	0.0001	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOA5—atherosclerosis	1.04e-05	0.0001	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CETP—atherosclerosis	1.02e-05	9.83e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.01e-05	9.72e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1e-05	9.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—PPARG—atherosclerosis	1e-05	9.61e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SOCS3—atherosclerosis	9.99e-06	9.61e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—MAPK3—atherosclerosis	9.99e-06	9.6e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SERPINE1—atherosclerosis	9.98e-06	9.6e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	9.91e-06	9.53e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—PPARG—atherosclerosis	9.85e-06	9.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	9.82e-06	9.44e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	9.79e-06	9.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SCARB1—atherosclerosis	9.79e-06	9.41e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MMP9—atherosclerosis	9.69e-06	9.32e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALOX5—atherosclerosis	9.68e-06	9.3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MMP3—atherosclerosis	9.65e-06	9.28e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IGF2—atherosclerosis	9.61e-06	9.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NFKB1—atherosclerosis	9.59e-06	9.22e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.54e-06	9.17e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NOS3—atherosclerosis	9.53e-06	9.16e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ABCG1—atherosclerosis	9.45e-06	9.08e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MAPK8—atherosclerosis	9.43e-06	9.06e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APOB—atherosclerosis	9.33e-06	8.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—HMGCR—atherosclerosis	9.25e-06	8.89e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EDN1—atherosclerosis	9.18e-06	8.82e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCL5—atherosclerosis	9.11e-06	8.76e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—SERPINE1—atherosclerosis	9.01e-06	8.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.94e-06	8.6e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—LPL—atherosclerosis	8.91e-06	8.56e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—FABP4—atherosclerosis	8.88e-06	8.54e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—LCAT—atherosclerosis	8.88e-06	8.54e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—SERPINE1—atherosclerosis	8.87e-06	8.53e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOA4—atherosclerosis	8.72e-06	8.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—VEGFA—atherosclerosis	8.7e-06	8.37e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NAMPT—atherosclerosis	8.68e-06	8.35e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PRKCG—atherosclerosis	8.66e-06	8.32e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.63e-06	8.3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—LIPC—atherosclerosis	8.63e-06	8.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—STAT3—atherosclerosis	8.62e-06	8.28e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IL6—atherosclerosis	8.6e-06	8.26e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOC3—atherosclerosis	8.57e-06	8.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP7A1—atherosclerosis	8.57e-06	8.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—LDLR—atherosclerosis	8.52e-06	8.19e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CXCL8—atherosclerosis	8.45e-06	8.13e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SPP1—atherosclerosis	8.44e-06	8.11e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.34e-06	8.02e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CETP—atherosclerosis	8.32e-06	8e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ABCA1—atherosclerosis	8.24e-06	7.92e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MAPK3—atherosclerosis	8.23e-06	7.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TGFB1—atherosclerosis	7.99e-06	7.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SCARB1—atherosclerosis	7.97e-06	7.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—AKT1—atherosclerosis	7.93e-06	7.62e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP27A1—atherosclerosis	7.92e-06	7.61e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PDGFB—atherosclerosis	7.8e-06	7.5e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.76e-06	7.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MMP9—atherosclerosis	7.65e-06	7.35e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AGT—atherosclerosis	7.62e-06	7.32e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—MAPK3—atherosclerosis	7.61e-06	7.32e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NFKB1—atherosclerosis	7.56e-06	7.27e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—HMGCR—atherosclerosis	7.53e-06	7.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOA2—atherosclerosis	7.51e-06	7.22e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	7.51e-06	7.22e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALOX15—atherosclerosis	7.51e-06	7.22e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	7.51e-06	7.22e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—LEP—atherosclerosis	7.47e-06	7.18e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APOE—atherosclerosis	7.47e-06	7.18e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MAPK8—atherosclerosis	7.44e-06	7.15e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ABCG5—atherosclerosis	7.42e-06	7.13e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CAV1—atherosclerosis	7.4e-06	7.11e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APOA1—atherosclerosis	7.38e-06	7.09e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—LPA—atherosclerosis	7.16e-06	6.88e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—HMOX1—atherosclerosis	7.07e-06	6.8e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—F2—atherosclerosis	7.04e-06	6.77e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—BGN—atherosclerosis	6.94e-06	6.67e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOA5—atherosclerosis	6.87e-06	6.6e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—VEGFA—atherosclerosis	6.87e-06	6.6e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—STAT3—atherosclerosis	6.8e-06	6.53e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.79e-06	6.53e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APOB—atherosclerosis	6.77e-06	6.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PIK3CG—atherosclerosis	6.74e-06	6.48e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—AKT1—atherosclerosis	6.74e-06	6.48e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ABCA1—atherosclerosis	6.71e-06	6.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—AKT1—atherosclerosis	6.64e-06	6.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	6.61e-06	6.35e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GSTM1—atherosclerosis	6.59e-06	6.34e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MAPK3—atherosclerosis	6.49e-06	6.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—LPL—atherosclerosis	6.47e-06	6.22e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALOX5—atherosclerosis	6.38e-06	6.14e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—INS—atherosclerosis	6.38e-06	6.13e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GPX1—atherosclerosis	6.31e-06	6.07e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TGFB1—atherosclerosis	6.3e-06	6.06e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCL2—atherosclerosis	6.27e-06	6.03e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IGF1—atherosclerosis	6.17e-06	5.93e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CD36—atherosclerosis	6.15e-06	5.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL6—atherosclerosis	6.02e-06	5.79e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—MAPK3—atherosclerosis	5.86e-06	5.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SERPINE1—atherosclerosis	5.86e-06	5.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—MTHFR—atherosclerosis	5.82e-06	5.6e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—MAPK3—atherosclerosis	5.77e-06	5.55e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—HMOX1—atherosclerosis	5.76e-06	5.53e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.73e-06	5.5e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PPARA—atherosclerosis	5.71e-06	5.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—LIPC—atherosclerosis	5.69e-06	5.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOC3—atherosclerosis	5.65e-06	5.44e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—LDLR—atherosclerosis	5.62e-06	5.4e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NOS3—atherosclerosis	5.59e-06	5.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—AKT1—atherosclerosis	5.55e-06	5.34e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—AGT—atherosclerosis	5.53e-06	5.32e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOB—atherosclerosis	5.51e-06	5.3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CETP—atherosclerosis	5.49e-06	5.28e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APOE—atherosclerosis	5.42e-06	5.21e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CAV1—atherosclerosis	5.37e-06	5.16e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GSTM1—atherosclerosis	5.36e-06	5.16e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APOA1—atherosclerosis	5.36e-06	5.15e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—LPL—atherosclerosis	5.26e-06	5.06e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SCARB1—atherosclerosis	5.26e-06	5.05e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GPX1—atherosclerosis	5.14e-06	4.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—AKT1—atherosclerosis	5.13e-06	4.93e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CD36—atherosclerosis	5e-06	4.81e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.96e-06	4.77e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CXCL8—atherosclerosis	4.96e-06	4.77e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PIK3CG—atherosclerosis	4.89e-06	4.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL6—atherosclerosis	4.75e-06	4.56e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.74e-06	4.56e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PPARG—atherosclerosis	4.72e-06	4.54e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PPARA—atherosclerosis	4.65e-06	4.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—INS—atherosclerosis	4.63e-06	4.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—AGT—atherosclerosis	4.5e-06	4.33e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MMP9—atherosclerosis	4.49e-06	4.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NFKB1—atherosclerosis	4.44e-06	4.27e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.42e-06	4.25e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOE—atherosclerosis	4.41e-06	4.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AKT1—atherosclerosis	4.38e-06	4.21e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CAV1—atherosclerosis	4.37e-06	4.2e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MAPK8—atherosclerosis	4.36e-06	4.2e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOA1—atherosclerosis	4.36e-06	4.19e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ALB—atherosclerosis	4.25e-06	4.08e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—NOS3—atherosclerosis	4.06e-06	3.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—VEGFA—atherosclerosis	4.03e-06	3.87e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—STAT3—atherosclerosis	3.99e-06	3.84e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.98e-06	3.83e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—AKT1—atherosclerosis	3.95e-06	3.8e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—AKT1—atherosclerosis	3.89e-06	3.74e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PPARG—atherosclerosis	3.84e-06	3.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MAPK3—atherosclerosis	3.81e-06	3.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.8e-06	3.65e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—INS—atherosclerosis	3.77e-06	3.62e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGS2—atherosclerosis	3.72e-06	3.57e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TGFB1—atherosclerosis	3.7e-06	3.56e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOB—atherosclerosis	3.64e-06	3.5e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.54e-06	3.4e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—LPL—atherosclerosis	3.47e-06	3.34e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALB—atherosclerosis	3.46e-06	3.32e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GPX1—atherosclerosis	3.39e-06	3.26e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NOS3—atherosclerosis	3.31e-06	3.18e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CD36—atherosclerosis	3.3e-06	3.17e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.13e-06	3.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPARA—atherosclerosis	3.07e-06	2.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGS2—atherosclerosis	3.02e-06	2.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AGT—atherosclerosis	2.97e-06	2.86e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOE—atherosclerosis	2.91e-06	2.8e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CAV1—atherosclerosis	2.88e-06	2.77e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOA1—atherosclerosis	2.88e-06	2.77e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6—atherosclerosis	2.79e-06	2.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.63e-06	2.52e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AKT1—atherosclerosis	2.57e-06	2.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPARG—atherosclerosis	2.53e-06	2.44e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—INS—atherosclerosis	2.49e-06	2.39e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALB—atherosclerosis	2.28e-06	2.19e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NOS3—atherosclerosis	2.18e-06	2.1e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.99e-06	1.92e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—AKT1—atherosclerosis	1.87e-06	1.8e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—AKT1—atherosclerosis	1.52e-06	1.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AKT1—atherosclerosis	1e-06	9.63e-06	CbGpPWpGaD
